Sean Grant
2023
In 2023, Sean Grant earned a total compensation of $1.8M as Chief Financial Officer at Vera Therapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Bonus | $18,400 |
|---|---|
| Non-Equity Incentive Plan | $165,600 |
| Option Awards | $1,119,820 |
| Salary | $455,000 |
| Other | $3,000 |
| Total | $1,761,820 |
Grant received $1.1M in option awards, accounting for 64% of the total pay in 2023.
Grant also received $18.4K in bonus, $165.6K in non-equity incentive plan, $455K in salary and $3K in other compensation.
Rankings
In 2023, Sean Grant's compensation ranked 630th out of 2,983 executives tracked by ExecPay. In other words, Grant earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 630 out of 2,983 | 79th |
Division Manufacturing | 352 out of 1,637 | 79th |
Major group Chemicals And Allied Products | 241 out of 906 | 73rd |
Industry group Drugs | 237 out of 869 | 73rd |
Industry Pharmaceutical Preparations | 152 out of 627 | 76th |
Source: SEC filing on April 3, 2024.
Grant's colleagues
We found two more compensation records of executives who worked with Sean Grant at Vera Therapeutics in 2023.